b44ff644-5028-436f-b36b-43b368703ccb.pdf

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

UNIVERSAL HEALTH INTERNATIONAL GROUP HOLDING LIMITED

大健康國際集團控股有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2211) POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 16 JUNE 2016

At the Annual General Meeting ("AGM") of Universal Health International Group Holding Limited (the "Company") held on 16 June 2016, all the proposed resolutions as set out in the notice of AGM dated 22 April 2016 (the "Notice") were taken by poll.

As at the date of AGM, the total number of issued shares of the Company was 2,400,000,000 shares, which was the total number of shares entitling the holders to attend and vote for or against the resolutions at the AGM. There were no shares entitling the holders to attend and abstain from voting in favour of the resolutions at the AGM as set out in Rule 13.40 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules") and no shareholder of the Company was required under the Listing Rules to abstain from voting at the AGM.

No parties have stated their intention in the circular to the shareholders dated 22 April 2016 containing the notice of the AGM to vote against or abstain from voting on any of the resolutions at the AGM.

The Company's share registrar, Computershare Hong Kong Investor Services Limited, was appointed as the scrutineer at the AGM for the purpose of vote-taking. Set out below are the poll results in respect of the respective resolutions put to the vote at the AGM:

ORDINARY RESOLUTIONS

Number of votes cast (Approximate percentage of total number of votes cast)

For

Against

1.

To receive and adopt the audited consolidated financial statements of the Company and its subsidiaries (the "Group") and the reports of the directors and auditor of the Company for the year ended 31 December 2015.

1,398,218,450 shares

(99.998570%)

20,000 shares

(0.001430%)

2.

(a) (i) To re-elect Mr. ZHAO Zehua as an executive director of the Company.

1,389,585,990 shares

(99.177123%)

11,529,460 shares

(0.822877%)

(ii) To re-elect Ms. HAO Jia as an independent non-executive director of the Company.

1,282,984,225 shares

(91.568773%)

118,131,225 shares

(8.431227%)

(iii) To re-elect Mr. JIN Dongkun as an executive director of the Company.

1,389,585,990 shares

(99.177123%)

11,529,460 shares

(0.822877%)

(iv) To re-elect Ms. CHIANG Su Hui Susie as an independent non-executive director of the Company.

1,401,096,450 shares

(99.998644%)

19,000 shares

(0.001356%)

(b) To authorize the board of directors (the "Board") of the Company to fix the remuneration of the directors of the Company.

1,400,103,450 shares

(99.934976%)

911,000 shares

(0.065024%)

3.

To re-appoint PricewaterhouseCoopers as the auditors of the Company and to authorise the Board to fix their remuneration.

1,401,115,450 shares

(100.000000%)

0 shares

(0.000000%)

ORDINARY RESOLUTIONS

Number of votes cast (Approximate percentage of total number of votes cast)

For

Against

4.

(A) To approve and grant the general mandate to the directors of the Company to allot, issue and deal with additional shares of the Company and to make or grant offers, agreements and options which might require the exercise of such powers (the "General Mandate") as set out in item 4.(A) of the Notice.

1,034,810,008 shares

(73.856156%)

366,305,442 shares

(26.143844%)

(B) To grant a general mandate to the directors of the Company to repurchase the Company's shares not exceeding 10% of the aggregate number of issued shares of the Company (the "Repurchase Mandate") as set out in item 4.(B) of the Notice.

1,401,015,450 shares

(99.999929%)

1,000 shares

(0.000071%)

(C) To extend the general mandate granted to the directors of the Company to allot, issue and deal with additional shares of the Company repurchased by the Company under the Repurchase Mandate as set out in item 4.(B) of the Notice.

1,044,829,783 shares

(74.571284%)

356,285,667 shares

(25.428716%)

Please refer to the Notice for the full version of the above Resolutions. As more than 50% of the valid votes were cast in favour of all of the Resolutions, all the Resolutions were duly passed by way of poll at the AGM.

By Order of the Board

Universal Health International Group Holding Limited Jin Dongtao

Chairman

Hong Kong, 16 June 2016

As at the date of this announcement, the Board comprises four executive directors, namely, Mr. Jin Dongtao, Mr. Jin Dongkun, Mr. Chu Chuanfu and Mr. Zhao Zehua and three independent non- executive directors, namely, Mr. Cheng Sheung Hing, Ms. Chiang Su Hui Susie and Ms. Hao Jia.

Jintian Pharmaceutical Group Ltd. published this content on 16 June 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 17 June 2016 02:09:08 UTC.

Original documenthttp://www.jtyyjt.com/d/file/touzizheguanxi/gonggaojigonghan/2016/2016-06-17/b6849b08b79138e58626158411aef161.pdf

Public permalinkhttp://www.publicnow.com/view/29D9376DAAEBD52ED021F8E54836850295D5B902